# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-002750
Filing Date
2019-04-30
Accepted
2019-04-30 16:01:37
Documents
6
Period of Report
2019-06-19
Effectiveness Date
2019-04-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | a2238576zdef14a.htm | DEF 14A | 339239
2 | G73784.JPG | g73784.jpg | GRAPHIC | 14578
3 | G27022BCI001.GIF | g27022bci001.gif | GRAPHIC | 184055
4 | G27022BCI002.GIF | g27022bci002.gif | GRAPHIC | 182218
5 | G27022BEI001.GIF | g27022bei001.gif | GRAPHIC | 100597
6 | G27022BEI002.GIF | g27022bei002.gif | GRAPHIC | 90217
| Complete submission text file | 0001047469-19-002750.txt |  | 1128128

Mailing Address 500 BOYLSTON STREET 11TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 11TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38223 | Film No.: 19781540
SIC: 2834 Pharmaceutical Preparations